American pharmaceutical company
Vertex Pharmaceuticals Seeks a Second Act With $4.9B Deal to Buy Alpine Immune: Vertex Pharmaceuticals announced a $4.9 billion deal to buy Alpine Immune ...
barrons.com/articles/vertex-pharmaceuticals-stock-alpine-immune-deal-a3a27f8e
Paid articlePaid
U.S. pharmaceutical firm Regeneron inflated the average price of its eye care drug Eylea while secretly reimbursing customers’ credit card fees in order to ... Show more www.occrp.org/en/daily/18654-us-pharmaceutical-company-accused-of-defrauding-hundreds-of-millions-from-medicare
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees ... Show more www.medscape.org/viewarticle/1000674
US Justice department files complaint against Regeneron, alleges fraudulent drug pricing
reuters.com/legal/us-justice-department-files-complaint-against-regeneron-alleges-fraudulent-drug-2024-04-10/
Test Your Ability to Manage Atopic Dermatitis: A Live Workshop Challenge: Are you up to date with the latest treatment options for managing atopic dermatitis ...
medscape.org/viewarticle/1000045
Bayer: New trouble with partner: There is a threat of trouble for Regeneron in the USA.
deraktionaer.de/artikel/pharma-biotech/bayer-neuer-aerger-beim-partner-20354901.html
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
US appeals court revives Regeneron's antitrust lawsuit against Novartis: A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals ...
reuters.com/legal/us-appeals-court-revives-regenerons-antitrust-lawsuit-against-novartis-2024-03-18/
Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)
seekingalpha.com/article/4677973-regeneron-pharmaceuticals-inc-regn-leerink-partners-global-biopharma-conference-transcript
Long Island's Regeneron science scholars: Where are they now?: Former LI honorees now are physicians, research scientists, Ivy League students, attorneys ...
newsday.com/long-island/education/long-island-regeneron-science-scholars-gajemyvj
🚀 Introducing the Immunology Learning Nexus - co-chaired by Drs Peter Lio, Philip Mease, and David Rubin. Dive into our new activities designed to improve ... Show more ms.spr.ly/6188cVS6C
Join us to engage with a multidisciplinary expert faculty panel on the current evidence and clinical considerations for JAK inhibitors across immune-mediated ... Show more
In the Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC
medscape.org/viewarticle/1000383
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
seekingalpha.com/article/4677673-regeneron-pharmaceuticals-inc-regn-management-presents-barclays-26th-annual-global-healthcare
Mawhiba prepares 35 young innovators for global science fair: JEDDAH: In collaboration with the Ministry of Education, the King Abdulaziz and His Companions ...
arabnews.com/node/2465841/saudi-arabia
Regeneron Pharmaceuticals: Time To Change My Strategy After Encouraging Q4 2024: Regeneron reported strong Q4/2023 earnings, exceeding expectations and showing ...
seekingalpha.com/article/4669269-regeneron-pharmaceuticals-time-to-change-my-strategy-after-encouraging-q42024
Paid articlePaid Regeneron Earnings Beat Forecasts as Sales of Updated Eye Drug Raise Hopes: Regeneron hopes to limit the damage from the expiration of the patent on its key drug ...
barrons.com/articles/regeneron-earnings-stock-eylea-14987aad
Paid articlePaid
$REGN | Regeneron Pharmaceuticals Q4 Earnings:
- Adj EPS $11.86 (Est. $10.77)
- Sales $3.43B (Est. $3.29B)
- Forecasts 2024 Adjusted R&D Expenses Of $4 ... Show more
US FDA approves Dupixent to treat younger kids with esophageal condition: The U.S. health regulator has approved the use of Regeneron and Sanofi's Dupixent to ...
reut.rs/3uaoBdF
Three high school seniors from three Nassau public schools have been named finalists in the national Regeneron Science Talent Search competition ... Show more tinyurl.com/2pubxccy #longisland #longislandny #liny #longislandnewyork #nassaucountyny #roslyn #jericho #syosset #nassaucounty #finalists #regeneron #science #linkinbio
Vertex non-opioid painkiller meets main goal in late-stage trials: Vertex Pharmaceuticals' (VRTX.O) experimental drug reduced acute, post-surgical pain without ...
reuters.com/business/healthcare-pharmaceuticals/vertex-non-opioid-pain-drug-succeeds-late-stage-trials-2024-01-30/
2seventy bio to sell experimental cell therapies, names new CEO: Cancer treatment maker 2seventy bio (TSVT.O) said it will sell all its experimental cell ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-buy-development-rights-2seventy-bios-cell-therapies-2024-01-30/
WSJ News Exclusive | Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs
wsj.com/health/pharma/drugmakers-raise-prices-of-ozempic-mounjaro-and-hundreds-of-other-drugs-bdac7051
Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That: Companies are investigating ways to prevent people from losing muscle when on popular ...
wsj.com/health/pharma/obesity-drugs-lead-to-muscle-losspharma-companies-want-to-fix-that-f2f5fe45
Regeneron (REGN) Stock Gains After Eye-Drug Patent Victory Over Viatris (VTRS): Regeneron Pharmaceuticals Inc. rose the most since August after a court ruled ...
bloomberg.com/news/articles/2023-12-27/regeneron-gains-after-eye-drug-patent-victory-over-viatris
Here's Why Regeneron Just Hit A Record High — Again: There's more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday ...
investors.com/news/technology/regn-stock-hits-a-record-high-again-as-it-tacks-on-new-wins/
Regeneron beats fourth-quarter revenue estimates: Regeneron (REGN.O) beat Wall Street estimates for fourth-quarter revenue on Friday as sales of its blockbuster ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-beats-quarterly-revenue-estimates-2024-02-02/
Quick Glance: South Africa's Goalkeeper Leads Team to Africa Cup of Nations Semi-Finals
- South Africa's Ronwen Williams saves four penalties, securing a spot in the Africa Cup of Nations semi-finals.
- Mothobi Mvala scores decisive penalty in 2-1 shootout win after 0-0 draw, sending South Africa to their first semi-final since 2000.
- Williams makes brilliant saves, carrying South Africa to victory after dominating the early exchanges and surviving several scares.
- South Africa to face Nigeria in semi-final match on Wednesday.
Regeneron Pharmaceuticals, Inc. (REGN) Q4 2023 Earnings Call Transcript: Regeneron Pharmaceuticals, Inc. (NASDAQ:NASDAQ:REGN) Q4 2023 Earnings Conference Call ...
seekingalpha.com/article/4667116-regeneron-pharmaceuticals-inc-regn-q4-2023-earnings-call-transcript
Regeneron's Push Into Obesity, Q4 2023 Earnings Review: Return to growth and improving growth prospects should translate to continued share price gains for ...
seekingalpha.com/article/4667130-regenerons-push-into-obesity-q4-2023-earnings-review
Paid articlePaid With the most semifinalists of any region in the country, Long Island has continued its successful streak in scientific prowess as 50 local high school seniors ... Show more tinyurl.com/8drvsyeh #longisland #longislandny #liny #longislandnewyork #longislandschools #regeneron #science #nassaucountyny #greatneckny #linkinbio
Long COVID: Case reports suggest benefits of monoclonal antibodies: Houston - Treatment with the antibody combination casirivimab/imdevimab ...
aerzteblatt.de/nachrichten/148922/Long-COVID-Fallberichte-weisen-auf-Nutzen-monoklonaler-Antikoerper-hin
NewsdayTV, Streaming Now | 7 PM | JAN 24, 2024
3 Long Island Regeneron finalists … Farmingdale State College donation … Islanders new coach#longisland
Oprah's flip on weight loss drugs is a sign of what's to come for the 'Ozempic trade' in 2024
cnbc.com/2023/12/25/oprahs-flip-on-weight-loss-drugs-is-a-sign-of-whats-to-come-for-the-ozempic-trade-in-2024.html
Paid articlePaid Regeneron preliminary Q4 US sales of Eylea below expectations: Regeneron Pharmaceuticals (REGN.O) on Monday reported eye drug Eylea's fourth-quarter preliminary ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-reports-preliminary-q4-us-sales-eylea-134-bln-2024-01-08/
Quick Glance: VW utilizing ChatGPT for driver conversations by mid-year
- Volkswagen integrating ChatGPT to enable driver conversations by mid-year.
- First vehicles with ChatGPT available in North America and Europe from early second quarter.
- AI system capable of recognizing and responding to various demands, such as temperature adjustments and displaying nearby restaurants.
If you can't build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
cnbc.com/2023/12/13/where-ma-could-be-heading-in-the-obesity-drug-space.html
Paid articlePaid SHAREHOLDER tip Regeneron: New record high - that inspires: The shares of the American biotech giant Regeneron rose to a new record high in the last trading week ...
deraktionaer.de/artikel/pharma-biotech/aktionaer-tipp-regeneron-neues-rekordhoch-das-befluegelt-20347630.html
Rare Tidbits: Underscoring Key Topics for the Care of Patients With Rare Hematologic Disorders
medscape.org/viewarticle/997918
Traditional company Bayer: The hunt for the blockbuster replacement: Bayer stumbles from one crisis to the next. Patents on important medications will soon ...
faz.net/aktuell/wirtschaft/unternehmen/pharmakonzern-bayer-die-jagd-nach-dem-blockbuster-ersatz-19410087.html
Paid articlePaid Regeneron: Important achievement - Stock on the hunt for records: On Wednesday, Regeneron Pharmaceuticals shares rose to a new record high during trading.
deraktionaer.de/artikel/pharma-biotech/regeneron-wichtiger-erfolg-aktie-auf-rekordjagd-20346591.html
Replimune's skin cancer therapy fails in mid-stage study, shares plunge: Replimune Group (REPL.O) said on Tuesday its experimental combination therapy to treat a ...
reuters.com/business/healthcare-pharmaceuticals/replimunes-skin-cancer-drug-fails-mid-stage-study-2023-12-05/
Regeneron Plots A Major Expansion That Could Add $4 Billion In Sales: Regeneron and Sanofi said Monday their blockbuster drug, Dupixent, significantly improved ...
investors.com/news/technology/regn-stock-rises-as-it-plans-a-major-expansion-for-blockbuster-dupixent/
Regeneron's High-Dose Eylea Is Off To A Strong Start: The launch of high-dose Eylea is off to a strong start in the U.S.
investors.com/news/technology/regn-stock-regeneron-earnings-q3-2023/
Regeneron Bulls, Bears Clash: Will Biotech Get Eylea Mojo Back?: The big debate for Regeneron: will the biotech company get its mojo back in its core eye disease ...
investors.com/research/ibd-stock-of-the-day/regn-stock-regeneron-bulls-bears-clash-eylea-mojo/
These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
cnbc.com/2023/10/22/glp-1-drugs-can-shrink-muscle-mass-these-stocks-are-trying-to-stop-it.html
Paid articlePaid Regeneron, Intellia to make gene editing therapies in expanded collaboration: Regeneron Pharmaceuticals (REGN.O) and Intellia Therapeutics (NTLA ...
reuters.com/business/healthcare-pharmaceuticals/regeneron-intellia-therapeutics-expand-research-collaboration-make-gene-editing-2023-10-03/
A New Way to Protect Against Heart Attacks: It is increasingly clear to researchers that inflammation can raise the risk of a heart attack ...
wsj.com/health/wellness/heart-attack-health-inflammation-drug-353dabf5
IW U.S. 500: Top Biotechnology and Pharmaceutical Companies (slideshow): The largest producers of drugs and gene therapies and the tools that support the life ...
industryweek.com/resources/the-industryweek-us-500/media-gallery/21268020/iw-us-500-top-biotechnology-and-pharmaceutical-companies-slideshow
US govt awards $1.4 bln for development of new COVID therapies, vaccines: The U.S. government said on Tuesday it had awarded $1.4 billion for the development of ...
reuters.com/business/healthcare-pharmaceuticals/us-govt-awards-14-bln-development-new-covid-therapies-vaccines-2023-08-22/
Quick Glance: US Govt Grants $1.4B for New COVID Therapies, Vaccines
- The US government has awarded $1.4 billion for the development of new therapies and vaccines against COVID-19.
- Regeneron Pharmaceuticals receives a $326 million contract for a new antibody therapy to prevent infections.
- The funding to Regeneron is part of the 'Project NextGen' initiative by the US Department of Health and Human Services.
- Additionally, $1 billion is allocated for mid-stage clinical trials of new COVID vaccines and $100 million to Global Health Investment Corp.
Former Stanford President Marc Tessier-Lavigne Steps Down From Regeneron Board: Marc Tessier-Lavigne, who resigned as president of Stanford University after ...
bloomberg.com/news/articles/2023-09-08/former-stanford-president-steps-down-from-regeneron-board
US FDA approves higher dose of Regeneron's eye disease drug Eylea: The U.S. Food and Drug Administration approved a higher dose version of Regeneron ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-regenerons-8-mg-dose-eye-disease-drug-eylea-2023-08-18/
Regeneron's Eylea could return to growth after nod to high-dose version- analysts
reuters.com/business/healthcare-pharmaceuticals/regenerons-eylea-could-return-growth-after-nod-high-dose-version-analysts-2023-08-21/
Why This Regeneron Approval 'Could Not Come Soon Enough' As Novartis Looms
investors.com/news/technology/regn-stock-climbs-as-fda-approves-high-dose-eylea-why-the-approval-could-not-come-soon-enough/
Regeneron, J&J Get US Funding to Develop New Covid-19 Vaccines, Treatments: Regeneron and Johnson & Johnson will receive millions of dollars in US government ...
bloomberg.com/news/articles/2023-08-22/regeneron-j-j-get-us-funding-to-develop-new-covid-therapies
The Unexpectedly Good News That Helped Regeneron Surge: Regeneron guided to a faster-than-expected approval timeline for a high dose of its eye drug Eylea on ...
investors.com/news/technology/regn-stock-regeneron-earnings-q2-2023/
DAX attempting to stabilize: Focus on Borussia Dortmund, Zoom, Bayer, Regeneron, Volkswagen and Covestro - this is important today
deraktionaer.de/artikel/indizes/dax-mit-stabilisierungsversuch-borussia-dortmund-zoom-bayer-regeneron-volkswagen-und-covestro-im-fokus-das-ist-heute-wichtig-20337967.html
US FDA declines to approve Regeneron's higher-dose Eylea, shares tumble: U.S. health regulators on Tuesday declined to approve a higher-dose version of Regeneron ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regeneron-high-dose-eylea-2023-06-27/
TODAY at 11am ET‼️@EyePointPharma President & COO, Jay Duker will be joining @MADExINxINDIA live on Benzinga TV! 📺
Set a Reminder!www.youtube.com/watch?v=463E4RJIZU4 We will be talking about the ... Show more @Regeneron
Sanofi: smoker's lung drug benefit was swift and sustained in trial: The benefits of Sanofi (SASY.PA) and Regeneron's (REGN.O) anti-inflammatory drug Dupixent ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-smokers-lung-drug-benefit-was-swift-sustained-trial-2023-05-22/
7 Undervalued Biotech Stocks: Even with biotech stocks performing well in the bear market, names including Moderna and Incyte are trading at a discount.
morningstar.com/stocks/7-undervalued-biotech-stocks
$6 billion in college scholarships are awarded each year. Here's what you need to know about applying
cnbc.com/2023/04/04/everything-students-need-to-know-about-college-scholarships.html
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
cnbc.com/2023/03/23/sanofi-regeneron-shares-pop-after-data-shows-asthma-drug-dupixent-may-also-treat-copd.html
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data: Sanofi's (SASY.PA) asthma drug Dupixent met all targets in a trial to treat "smoker's lung" ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-regenerons-dupixent-meets-endpoints-clinical-trial-2023-03-23/
Amgen-Sanofi patent case divides makers of antibody drugs: Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S ...
reuters.com/legal/amgen-sanofi-patent-case-divides-makers-antibody-drugs-2023-03-27/
This week's best performers include Regeneron and these two solar stocks: Equities took a volatile ride, as investors shifted attention between the latest Fed ...
cnbc.com/2023/03/24/this-weeks-best-performers-include-regeneron-and-these-two-solar-stocks.html
Paid articlePaid
A new paradigm for managing data: Open data lakehouse architectures speed insights and deliver self-service analytics capabilities.
technologyreview.com/2023/03/17/1069688/a-new-paradigm-for-managing-data/
Jefferies says Regeneron's Dupixent drug could drive shares 15% higher: Regeneron's Dupixent drug could serve as the next big catalyst for shares of the ...
cnbc.com/2023/03/24/jefferies-says-regenerons-dupixent-drug-could-drive-shares-15percent-higher.html
Paid articlePaid
Here's one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
marketwatch.com/story/heres-one-for-the-battered-bulls-the-second-largest-sector-in-the-s-p-500-is-stirring-to-life-says-this-strategist-5e179744
Paid articlePaid
Sanofi, Regeneron’s Dupixent shows promise as ‘smoker’s lung’ drug: Sanofi’s asthma and eczema drug Dupixent met all targets in a trial to treat “smoker’s lung ...
english.alarabiya.net/News/world/2023/03/23/Sanofi-Regeneron-s-Dupixent-shows-promise-as-smoker-s-lung-drug
Give Your Employees the Tools They Need to Be Productive - SPONSOR CONTENT FROM ADOBE
hbr.org/sponsored/2022/11/give-your-employees-the-tools-they-need-to-be-productive
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics